Clinical trial for Pancreatic Ductal Adenocarcinoma (PDAC)
Official title Reach and Engagement of GENetic Education, Risk Assessment, and TEsting Feasibility Trial
ClinicalTrials.gov ID: NCT07787156
What this study is testing
- What it's testing
- This study will test a remote approach to help people who may be at higher risk for pancreatic cancer learn about and decide whether to get genetic testing and a blood test that looks for signs of several cancers (MCED testing).
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Aged 50 years or older OR 10 years younger than the earliest PDAC diagnosis in a family member
- Current Medicaid enrollment and/or Black and/or Latino/a
- Willingness to travel to Dana-Farber Cancer Institute in Boston, MA, for diagnostic testing if MCED screening test indicates possible malignancy
- Living in the state of Massachusetts
- No prior multi-gene panel genetic testing related to PDAC genetic risk
You likely can't join if
- Less than age 50 years or age not within 10 years of the earliest PDAC diagnosis in their family
- Cancer diagnosis in the last 3 years (excluding non-melanoma skin cancers)
- Currently pregnant
- Insurance other than Medicaid or race/ethnicity other than Black or Latino/a
- Prior genetic testing related to PDAC genetic risk
- Genetic counseling in the last 3 years
See the full eligibility criteria
- Aged 50 years or older OR 10 years younger than the earliest PDAC diagnosis in a family member
- Current Medicaid enrollment and/or Black and/or Latino/a
- Willingness to travel to Dana-Farber Cancer Institute in Boston, MA, for diagnostic testing if MCED screening test indicates possible malignancy
- Living in the state of Massachusetts
- No prior multi-gene panel genetic testing related to PDAC genetic risk
- Internet access to complete study surveys
- English speaking
- Willing to complete study surveys
- At least one first-degree relative with a PDAC diagnosis by participant report OR Any blood relative with a known pathogenic or likely pathogenic variant in a cancer susceptibility gene related to PDAC by participant...
- Less than age 50 years or age not within 10 years of the earliest PDAC diagnosis in their family
- Cancer diagnosis in the last 3 years (excluding non-melanoma skin cancers)
- Currently pregnant
- Insurance other than Medicaid or race/ethnicity other than Black or Latino/a
- Prior genetic testing related to PDAC genetic risk
- Genetic counseling in the last 3 years
- Living in a state other than Massachusetts
- Language other than English
- Three members of the same family already enrolled in the study
The study team makes the final eligibility decision.
Where it is enrolling
- Boston, Massachusetts, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Boston, Massachusetts, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.